Ashish Upadhyay MD
Associate Professor, Nephrology
Program Director, Nephrology Fellowship Program
72 East Concord Street | (617) 638-6500ashish.upadhyay@bmc.org
ashishu@bu.edu

Sections
Nephrology
Centers
Evans Center for Interdisciplinary Biomedical Research
Biography
Dr. Upadhyay is a board-certified nephrologist with academic interests in examining the interactions between metabolic and vascular diseases and CKD. He has conducted epidemiologic research in the Framingham Heart Study, led the evidence review team for the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on lipid management, participated in the evidence review teams for the KDIGO clinical practice guidelines on blood pressure and anemia management, and, currently, serves as one of the site investigators for the Kidney Precision Medicine Project (KPMP). At BU, in addition to directing the nephrology fellowship program, Dr. Upadhyay oversees research and EBM curriculum of the medicine residency program, and is a key faculty in BU’s NIH R38-funded research in residency program. He also has a special interest in hemodialysis systems and serves as a voting member of the Association for the Advancement of Medical Instrumentation’s Renal Disease and Detoxification Committee, the primary source of national and international consensus standards for hemodialysis technology and dialysis water sterilization processes. Dr. Upadhyay is the recipient of the 2021 Program Leadership Award from Boston Medical Center and the 2022 Robert Dawson Evans Special Recognition Teaching Award from the Department of Medicine.
Other Positions
Education
MBBS, Tribhuvan University
Publications
Upadhyay A, Haider L. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease: Clinical Evidence and Potential Adverse Events. Clin Diabetes. 2025; 43(1):43-52. PMID: 39829701.
Published on 9/1/2024Upadhyay A, Haider L. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease: Clinical Evidence and Potential Adverse Events. Clin Diabetes. 2024; 43(1):43-52. PMID: 39829701.
Published on 3/25/2024Upadhyay A. SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback. Kidney360. 2024 May 01; 5(5):771-782. PMID: 38523127.
Published on 1/14/2023Kamel MH, Upadhyay A, Borkan SC. Intractable hyponatremia complicated by a reset osmostat: a case report. J Med Case Rep. 2023 Jan 14; 17(1):13. PMID: 36639685.
Published on 1/1/2022Bonner R, Stewart J, Upadhyay A, Bruce RD, Taylor JL. A Primary Care Intervention to Increase HIV Pre-Exposure Prophylaxis (PrEP) Uptake in Patients with Syphilis. J Int Assoc Provid AIDS Care. 2022 Jan-Dec; 21:23259582211073393. PMID: 35001723.
Published on 8/13/2021Ataklte F, Song RJ, Upadhyay A, Musa Yola I, Vasan RS, Xanthakis V. Association of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study. J Am Heart Assoc. 2021 08 17; 10(16):e020301. PMID: 34387110.
Published on 6/4/2021Kamel MH, Mahmoud H, Zhen A, Liu J, Bielick CG, Mostaghim A, Lin N, Chitalia V, Ilori T, Waikar SS, Upadhyay A. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS One. 2021; 16(6):e0252679. PMID: 34086775.
Published on 9/23/2020Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic Kidney Disease. Prim Care. 2020 Dec; 47(4):645-659. PMID: 33121634.
Published on 4/21/2020Verma A, Patel AB, Upadhyay A, Waikar SS. CREDENCE: Significant Victory for Diabetic Kidney Disease. Trends Endocrinol Metab. 2020 06; 31(6):391-393. PMID: 32327275.
Published on 4/7/2020Neupane G, Acharya S, Bhattarai M, Upadhyay A, Belbase B, Bhandari M, Pandeya D, Pokharel S, Ghimire S, Thapa G, Karmacharya B, Bhatt MR, Spertus JA, Neupane D, Timsina L, Pokharel Y. Study, Design, and Rationale of Noncommunicable Diseases in Nepal (NCD Nepal) Study: A Community-Based Prospective Epidemiological and Implementation Study in Rural Nepal. Glob Adv Health Med. 2020; 9:2164956120917379. PMID: 32284911.